Omepral Side Effects|
|
Did You Have a Omepral Side Effect? How Effective is Omepral for You? |
Omepral Forum |
Omepral Adverse Effect Reports (FDA)
Showing 1-25 of 329 Next Page >
Anaemia (7472477-9)
on May 09, 2011 Female patient from JAPAN , 41 years of age, weighting 138.9 lb, was treated with Omepral(View Usage). Patient experienced the following unwanted or unexpected effects: anaemia. Omepral dosage: N/A.
Patient was taking other medications:
Anaemia (7445550-9)
Patient was taking Omepral (View Usage). Patient had the following side effects: anaemia on Apr 26, 2011 from JAPAN Additional patient health information: Female patient , 41 years of age, weighting 138.9 lb, . Omepral dosage: N/A.
Patient was taking other medications:
Toxic Epidermal Necrolysis, Gastrointestinal Necrosis (7443044-8)
Adverse event was reported on Apr 22, 2011 by a Male patient taking Omepral (View Usage) (Dosage: N/A) was diagnosed with
Retinal Vein Occlusion (7440047-4)
on Apr 12, 2011 Male patient from JAPAN , 63 years of age, weighting 141.1 lb, was treated with Omepral (View Usage). Patient experienced the following unwanted or unexpected effects: retinal vein occlusion. Omepral dosage: Daily Dose 20 Mg.
Patient was taking other medications:
Neoplasm Malignant, Ascites, Intestinal T-cell Lymphoma, Abdominal Distension (7440025-5)
on Apr 20, 2011 Female patient from JAPAN , 48 years of age, was treated with Omepral(View Usage). Patient had the following side effects: neoplasm malignant, ascites, intestinal t-cell lymphoma, abdominal distension. Omepral dosage: N/A.
Patient was taking other medications:
Iron Deficiency Anaemia (7435888-3)
Patient was taking Omepral (View Usage). After Omepral was administered, patient had the following side effects: iron deficiency anaemia on Apr 15, 2011 from JAPAN Additional patient health information: Female patient , 80 years of age, . Omepral dosage: N/A.
Anaemia, Platelet Count Decreased, Renal Impairment, Hepatic Function Abnormal, Atrial Fibrillation (7423594-0)
Adverse event was reported on Apr 06, 2011 by a Male patient taking Omepral (View Usage) (Dosage: N/A) . Location: JAPAN , 53 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, platelet count decreased, renal impairment, hepatic function abnormal, atrial fibrillation (What is atrial fibrillation?).
Patient was taking other medications:
Nephrotic Syndrome (7399671-X)
on Mar 29, 2011 Male patient from JAPAN , weighting 154.3 lb, was diagnosed with
Patient was taking other medications:
Interstitial Lung Disease, Pneumothorax (7395245-5)
on Mar 31, 2011 Female patient from JAPAN , weighting 90.39 lb, was treated with Omepral(View Usage). After Omepral was administered, patient had the following side effects: interstitial lung disease, pneumothorax. Omepral dosage: N/A.
Patient was taking other medications:
Cardio-respiratory Arrest (7388749-2)
Patient was taking Omepral (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest on Mar 22, 2011 from JAPAN Additional patient health information: Male patient , 67 years of age, weighting 99.21 lb, . Omepral dosage: N/A.
Patient was taking other medications:
Ichthyosis, Palpitations, Dry Mouth (7388747-9)
Adverse event was reported on Feb 21, 2011 by a Female patient taking Omepral (View Usage) (Dosage: N/A) . Location: JAPAN , weighting 127.9 lb, Patient had the following side effects: ichthyosis, palpitations, dry mouth.
Patient was taking other medications:
Sepsis, Intestinal Perforation (7352061-8)
on Mar 09, 2011 Female patient from JAPAN , 37 years of age, was treated with Omepral (View Usage). After Omepral was administered, patient had the following side effects: sepsis (What is sepsis?), intestinal perforation. Omepral dosage: N/A.
Patient was taking other medications:
Idiopathic Thrombocytopenic Purpura (7348493-4)
on Mar 02, 2011 Female patient from JAPAN , 69 years of age, was treated with Omepral(View Usage). Patient experienced the following unwanted or unexpected effects: idiopathic thrombocytopenic purpura. Omepral dosage: N/A. Patient was hospitalized.
Pneumonia (7341696-4)
Patient was taking Omepral (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?) on Feb 24, 2011 from JAPAN Additional patient health information: Male patient , weighting 127.9 lb, was diagnosed with
Patient was taking other medications:
Injection Site Haemorrhage (7324054-8)
Adverse event was reported on Feb 25, 2011 by a Male patient taking Omepral (View Usage) (Dosage: N/A) was diagnosed with
Patient was taking other medications:
Haemoglobin Decreased, Decreased Appetite, Stomatitis (7320976-2)
on Feb 21, 2011 Male patient from JAPAN , 73 years of age, weighting 108.0 lb, was diagnosed with
Patient was taking other medications:
Neutropenic Infection, White Blood Cell Count Decreased, Platelet Count Decreased, Paronychia (7294384-7)
on Feb 07, 2011 Male patient from JAPAN , 66 years of age, weighting 110.2 lb, was treated with Omepral(View Usage). Patient had the following side effects: neutropenic infection, white blood cell count decreased, platelet count decreased, paronychia. Omepral dosage: N/A.
Patient was taking other medications:
Liver Disorder, Jaundice (7282058-8)
Patient was taking Omepral (View Usage). After Omepral was administered, patient had the following side effects: liver disorder, jaundice (What is jaundice?) on Jan 27, 2011 from JAPAN Additional patient health information: Female patient , 22 years of age, weighting 138.9 lb, was diagnosed with
Patient was taking other medications:
Cerebral Haemorrhage (7279350-X)
Adverse event was reported on Jan 31, 2011 by a Male patient taking Omepral (View Usage) (Dosage: N/A) . Location: JAPAN , 85 years of age, Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage.
Patient was taking other medications:
Blood Albumin Decreased, Erythema Multiforme, Hepatic Failure, Hypothyroidism (7278070-5)
on Jan 26, 2011 Female patient from JAPAN , weighting 153.2 lb, was diagnosed with
Patient was taking other medications:
Jaundice, Hepatic Function Abnormal (7265253-3)
on Jan 20, 2011 Female patient from JAPAN , 23 years of age, was treated with Omepral(View Usage). After Omepral was administered, patient had the following side effects: jaundice (What is jaundice?), hepatic function abnormal. Omepral dosage: N/A.
Patient was taking other medications:
Ascites, Hepatic Neoplasm Malignant, Liver Disorder (7250236-X)
Patient was taking Omepral (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, hepatic neoplasm malignant, liver disorder on Jan 05, 2011 from JAPAN Additional patient health information: Male patient , weighting 169.8 lb, was diagnosed with
Patient was taking other medications:
Dry Mouth, Palpitations, Pruritus (7248879-2)
Adverse event was reported on Jan 20, 2011 by a Female patient taking Omepral (View Usage) (Dosage: N/A) . Location: JAPAN , weighting 127.9 lb, Patient had the following side effects: dry mouth, palpitations, pruritus.
Patient was taking other medications:
Hypochloraemia, Hypoglycaemia, Hypolipidaemia, Hyponatraemia, Hypoalbuminaemia, Hypoproteinaemia, Hypokalaemia (7223050-9)
on Jan 05, 2011 Male patient from JAPAN , 79 years of age, weighting 103.6 lb, was treated with Omepral (View Usage). After Omepral was administered, patient had the following side effects: hypochloraemia, hypoglycaemia, hypolipidaemia, hyponatraemia, hypoalbuminaemia, hypoproteinaemia, hypokalaemia. Omepral dosage: N/A.
Patient was taking other medications:
Cerebral Haemorrhage (7217135-0)
on Jan 06, 2011 Male patient from JAPAN , 85 years of age, was treated with Omepral(View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage. Omepral dosage: N/A.
Patient was taking other medications:
on May 09, 2011 Female patient from JAPAN , 41 years of age, weighting 138.9 lb, was treated with Omepral(View Usage). Patient experienced the following unwanted or unexpected effects: anaemia. Omepral dosage: N/A.
Patient was taking other medications:
- PLAVIX (View Plavix Review and Plavix Label )
- JUVELA (View Juvela Review and Juvela Label )
Anaemia (7445550-9)
Patient was taking Omepral (View Usage). Patient had the following side effects: anaemia on Apr 26, 2011 from JAPAN Additional patient health information: Female patient , 41 years of age, weighting 138.9 lb, . Omepral dosage: N/A.
Patient was taking other medications:
- PLAVIX (View Plavix Review and Plavix Label )
- JUVELA (View Juvela Review and Juvela Label )
Toxic Epidermal Necrolysis, Gastrointestinal Necrosis (7443044-8)
Adverse event was reported on Apr 22, 2011 by a Male patient taking Omepral (View Usage) (Dosage: N/A) was diagnosed with
- stress ulcer
Retinal Vein Occlusion (7440047-4)
on Apr 12, 2011 Male patient from JAPAN , 63 years of age, weighting 141.1 lb, was treated with Omepral (View Usage). Patient experienced the following unwanted or unexpected effects: retinal vein occlusion. Omepral dosage: Daily Dose 20 Mg.
Patient was taking other medications:
- NEXAVAR (400 Mg, Bid) (View Nexavar Review and Nexavar Label )
Neoplasm Malignant, Ascites, Intestinal T-cell Lymphoma, Abdominal Distension (7440025-5)
on Apr 20, 2011 Female patient from JAPAN , 48 years of age, was treated with Omepral(View Usage). Patient had the following side effects: neoplasm malignant, ascites, intestinal t-cell lymphoma, abdominal distension. Omepral dosage: N/A.
Patient was taking other medications:
- GLEEVEC (300 Mg, Daily) (View Gleevec Review and Gleevec Label )
Iron Deficiency Anaemia (7435888-3)
Patient was taking Omepral (View Usage). After Omepral was administered, patient had the following side effects: iron deficiency anaemia on Apr 15, 2011 from JAPAN Additional patient health information: Female patient , 80 years of age, . Omepral dosage: N/A.
Anaemia, Platelet Count Decreased, Renal Impairment, Hepatic Function Abnormal, Atrial Fibrillation (7423594-0)
Adverse event was reported on Apr 06, 2011 by a Male patient taking Omepral (View Usage) (Dosage: N/A) . Location: JAPAN , 53 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, platelet count decreased, renal impairment, hepatic function abnormal, atrial fibrillation (What is atrial fibrillation?).
Patient was taking other medications:
- MARZULENE (View Marzulene Review and Marzulene Label )
- FUNGIZONE (View Fungizone Review and Fungizone Label )
- NEUART (View Neuart Review and Neuart Label )
- MEROPENEM (View Meropenem Review and Meropenem Label )
Nephrotic Syndrome (7399671-X)
on Mar 29, 2011 Male patient from JAPAN , weighting 154.3 lb, was diagnosed with
- prophylaxis against gastrointestinal ulcer
- polyuria
Patient was taking other medications:
- LASIX (Daily Dose 40 Mg) (View Lasix Review and Lasix Label )
- ASPIRIN \^BAYER\^ (JP ASPIRIN) (View Aspirin \^bayer\^ (jp Aspirin) Review and Aspirin \^bayer\^ (jp Aspirin) Label )
- PERSANTIN (Daily Dose 300 Mg) (View Persantin Review and Persantin Label )
- DIOVAN (Daily Dose 80 Mg) (View Diovan Review and Diovan Label )
- NEXAVAR (400 Mg, Bid) (View Nexavar Review and Nexavar Label )
- AMLODIN (Daily Dose 5 Mg) (View Amlodin Review and Amlodin Label )
- URSO 250 (Daily Dose 600 Mg) (View Urso 250 Review and Urso 250 Label )
- LIPITOR (Daily Dose 10 Mg) (View Lipitor Review and Lipitor Label )
Interstitial Lung Disease, Pneumothorax (7395245-5)
on Mar 31, 2011 Female patient from JAPAN , weighting 90.39 lb, was treated with Omepral(View Usage). After Omepral was administered, patient had the following side effects: interstitial lung disease, pneumothorax. Omepral dosage: N/A.
Patient was taking other medications:
- PLETAL (View Pletal Review and Pletal Label )
- ASPIRIN (View Aspirin Review and Aspirin Label )
- PLAVIX (View Plavix Review and Plavix Label )
- ALFAROL (View Alfarol Review and Alfarol Label )
Cardio-respiratory Arrest (7388749-2)
Patient was taking Omepral (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest on Mar 22, 2011 from JAPAN Additional patient health information: Male patient , 67 years of age, weighting 99.21 lb, . Omepral dosage: N/A.
Patient was taking other medications:
- DAIKENTYUTO (View Daikentyuto Review and Daikentyuto Label )
- DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label )
- PHENOBAL (Powder.) (View Phenobal Review and Phenobal Label )
- EBASTINE (View Ebastine Review and Ebastine Label )
- MYSLEE (View Myslee Review and Myslee Label )
- PLETAL (View Pletal Review and Pletal Label )
- ITOROL (View Itorol Review and Itorol Label )
- OLMETEC (View Olmetec Review and Olmetec Label )
Ichthyosis, Palpitations, Dry Mouth (7388747-9)
Adverse event was reported on Feb 21, 2011 by a Female patient taking Omepral (View Usage) (Dosage: N/A) . Location: JAPAN , weighting 127.9 lb, Patient had the following side effects: ichthyosis, palpitations, dry mouth.
Patient was taking other medications:
- MUCOSTA (Unk) (View Mucosta Review and Mucosta Label )
- ITOROL (20 Mg, Bid) (View Itorol Review and Itorol Label )
- KELNAC (Unk) (View Kelnac Review and Kelnac Label )
- PREDONINE (5 Mg, Bid) (View Predonine Review and Predonine Label )
- VESICARE (2.5 Mg, Qid) (View Vesicare Review and Vesicare Label )
- ZADITEN (Unk) (View Zaditen Review and Zaditen Label )
Sepsis, Intestinal Perforation (7352061-8)
on Mar 09, 2011 Female patient from JAPAN , 37 years of age, was treated with Omepral (View Usage). After Omepral was administered, patient had the following side effects: sepsis (What is sepsis?), intestinal perforation. Omepral dosage: N/A.
Patient was taking other medications:
- ASPARA CA (View Aspara-ca Review and Aspara-ca Label )
- DEPAKENE (View Depakene Review and Depakene Label )
- TACROLIMUS (View Tacrolimus Review and Tacrolimus Label )
- URSO 250 (View Urso 250 Review and Urso 250 Label )
- ALFAROL (View Alfarol Review and Alfarol Label )
- BLOPRESS (View Blopress Review and Blopress Label )
- LIPITOR (View Lipitor Review and Lipitor Label )
- PRORENAL (View Prorenal Review and Prorenal Label )
Idiopathic Thrombocytopenic Purpura (7348493-4)
on Mar 02, 2011 Female patient from JAPAN , 69 years of age, was treated with Omepral(View Usage). Patient experienced the following unwanted or unexpected effects: idiopathic thrombocytopenic purpura. Omepral dosage: N/A. Patient was hospitalized.
Pneumonia (7341696-4)
Patient was taking Omepral (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?) on Feb 24, 2011 from JAPAN Additional patient health information: Male patient , weighting 127.9 lb, was diagnosed with
- gastritis
Patient was taking other medications:
- MUCOSTA (Daily Dose 300 Mg) (View Mucosta Review and Mucosta Label )
- OLMETEC (Daily Dose 20 Mg) (View Olmetec Review and Olmetec Label )
- ALFAROL (Daily Dose .75 ?g) (View Alfarol Review and Alfarol Label )
- LORCAM (Daily Dose 12 Mg) (View Lorcam Review and Lorcam Label )
- URSO 250 (Daily Dose 600 Mg) (View Urso 250 Review and Urso 250 Label )
- MAGLAX (Daily Dose 990 Mg) (View Maglax Review and Maglax Label )
- GABAPENTIN (Daily Dose 1200 Mg) (View Gabapentin Review and Gabapentin Label )
- OXINORM (Daily Dose 7.5 Mg) (View Oxinorm Review and Oxinorm Label )
Injection Site Haemorrhage (7324054-8)
Adverse event was reported on Feb 25, 2011 by a Male patient taking Omepral (View Usage) (Dosage: N/A) was diagnosed with
- reflux oesophagitis
- neurogenic bladder
Patient was taking other medications:
- BLADDERON (View Bladderon Review and Bladderon Label )
- MIKELAN LA (View Mikelan La Review and Mikelan La Label )
- ODYNE (View Odyne Review and Odyne Label )
- POLLAKISU (View Pollakisu Review and Pollakisu Label )
- ALDACTONE (View Aldactone Review and Aldactone Label )
- ALOSENN (View Alosenn Review and Alosenn Label )
- AZ (View Az Review and Az Label )
- ZOLADEX (View Zoladex Review and Zoladex Label )
Haemoglobin Decreased, Decreased Appetite, Stomatitis (7320976-2)
on Feb 21, 2011 Male patient from JAPAN , 73 years of age, weighting 108.0 lb, was diagnosed with
- gastric ulcer
Patient was taking other medications:
- ZYVOX (600 Mg, 2x/day) (View Zyvox Review and Zyvox Label )
- PREDONINE (Unk) (View Predonine Review and Predonine Label )
- URINORM (50 Mg, 1x/day) (View Urinorm Review and Urinorm Label )
- BENET (17.5 Mg, Weekly) (View Benet Review and Benet Label )
- CALBLOCK (16 Mg, 1x/day) (View Calblock Review and Calblock Label )
Neutropenic Infection, White Blood Cell Count Decreased, Platelet Count Decreased, Paronychia (7294384-7)
on Feb 07, 2011 Male patient from JAPAN , 66 years of age, weighting 110.2 lb, was treated with Omepral(View Usage). Patient had the following side effects: neutropenic infection, white blood cell count decreased, platelet count decreased, paronychia. Omepral dosage: N/A.
Patient was taking other medications:
- MAGMITT (View Magmitt Review and Magmitt Label )
- PANITUMUMAB (6 Mg/kg, Q2wk) (View Panitumumab Review and Panitumumab Label )
- RIZE (View Rize Review and Rize Label )
- BENZALIN (View Benzalin Review and Benzalin Label )
- METHYCOBAL (View Methycobal Review and Methycobal Label )
- LOXONIN (View Loxonin Review and Loxonin Label )
Liver Disorder, Jaundice (7282058-8)
Patient was taking Omepral (View Usage). After Omepral was administered, patient had the following side effects: liver disorder, jaundice (What is jaundice?) on Jan 27, 2011 from JAPAN Additional patient health information: Female patient , 22 years of age, weighting 138.9 lb, was diagnosed with
- reflux oesophagitis
Patient was taking other medications:
- PARIET (View Pariet Review and Pariet Label )
- ELIETEN (View Elieten Review and Elieten Label )
- PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label )
- KAMOSTAAL (View Kamostaal Review and Kamostaal Label )
- TAKEPRON (View Takepron Review and Takepron Label )
- GANATON (View Ganaton Review and Ganaton Label )
- GASMOTIN (View Gasmotin Review and Gasmotin Label )
Cerebral Haemorrhage (7279350-X)
Adverse event was reported on Jan 31, 2011 by a Male patient taking Omepral (View Usage) (Dosage: N/A) . Location: JAPAN , 85 years of age, Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage.
Patient was taking other medications:
- BEZATOL SR (View Bezatol Sr Review and Bezatol Sr Label )
- FRANDOL (View Frandol Review and Frandol Label )
- URIEF (View Urief Review and Urief Label )
- IRBETAN (View Irbetan Review and Irbetan Label )
- ASPIRIN (View Aspirin Review and Aspirin Label )
Blood Albumin Decreased, Erythema Multiforme, Hepatic Failure, Hypothyroidism (7278070-5)
on Jan 26, 2011 Female patient from JAPAN , weighting 153.2 lb, was diagnosed with
- reflux oesophagitis
- hepatic neoplasm malignant
- hypertension
Patient was taking other medications:
- NEXAVAR (No Administration At Morning 26-nov-2009 And Morning 28-nov-2009) (View Nexavar Review and Nexavar Label )
- AMLODIPINE (5 Mg (daily Dose), , Oral) (View Amlodipine Review and Amlodipine Label )
- BLOPRESS (8 Mg (daily Dose), , Oral) (View Blopress Review and Blopress Label )
- FLUITRAN (2 Mg (daily Dose), , Oral) (View Fluitran Review and Fluitran Label )
- BARACLUDE (0.5 Mg (daily Dose), , Oral) (View Baraclude Review and Baraclude Label )
Jaundice, Hepatic Function Abnormal (7265253-3)
on Jan 20, 2011 Female patient from JAPAN , 23 years of age, was treated with Omepral(View Usage). After Omepral was administered, patient had the following side effects: jaundice (What is jaundice?), hepatic function abnormal. Omepral dosage: N/A.
Patient was taking other medications:
- GASMOTIN (View Gasmotin Review and Gasmotin Label )
Ascites, Hepatic Neoplasm Malignant, Liver Disorder (7250236-X)
Patient was taking Omepral (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, hepatic neoplasm malignant, liver disorder on Jan 05, 2011 from JAPAN Additional patient health information: Male patient , weighting 169.8 lb, was diagnosed with
- prophylaxis against gastrointestinal ulcer
Patient was taking other medications:
- URSO 250 (600 Mg (daily Dose), , Oral) (View Urso 250 Review and Urso 250 Label )
- LASIX (40 Mg (daily Dose), , Oral) (View Lasix Review and Lasix Label )
- NAIXAN (300 Mg (daily Dose), , Oral) (View Naixan Review and Naixan Label )
- NOVAMIN (View Novamin Review and Novamin Label )
- NEXAVAR (View Nexavar Review and Nexavar Label )
- LIVACT (3 Df (daily Dose), , Oral) (View Livact Review and Livact Label )
- OXINORM (View Oxinorm Review and Oxinorm Label )
- ALDACTONE (100 Mg (daily Dose), , Oral) (View Aldactone Review and Aldactone Label )
Dry Mouth, Palpitations, Pruritus (7248879-2)
Adverse event was reported on Jan 20, 2011 by a Female patient taking Omepral (View Usage) (Dosage: N/A) . Location: JAPAN , weighting 127.9 lb, Patient had the following side effects: dry mouth, palpitations, pruritus.
Patient was taking other medications:
- ZADITEN (Unk) (View Zaditen Review and Zaditen Label )
- ITOROL (20 Mg, Bid) (View Itorol Review and Itorol Label )
- PREDONINE (5 Mg, Bid) (View Predonine Review and Predonine Label )
- MUCOSTA (Unk) (View Mucosta Review and Mucosta Label )
- KELNAC (Unk) (View Kelnac Review and Kelnac Label )
- VESICARE (2.5 Mg, Qid) (View Vesicare Review and Vesicare Label )
Hypochloraemia, Hypoglycaemia, Hypolipidaemia, Hyponatraemia, Hypoalbuminaemia, Hypoproteinaemia, Hypokalaemia (7223050-9)
on Jan 05, 2011 Male patient from JAPAN , 79 years of age, weighting 103.6 lb, was treated with Omepral (View Usage). After Omepral was administered, patient had the following side effects: hypochloraemia, hypoglycaemia, hypolipidaemia, hyponatraemia, hypoalbuminaemia, hypoproteinaemia, hypokalaemia. Omepral dosage: N/A.
Patient was taking other medications:
- DIGOXIN (View Digoxin Review and Digoxin Label )
- URIEF (View Urief Review and Urief Label )
- BEPRICOR (View Bepricor Review and Bepricor Label )
- VERAPAMIL HCL (View Verapamil Hcl Review and Verapamil Hcl Label )
- HYZAAR (View Hyzaar Review and Hyzaar Label )
- DISOPYRAMIDE (View Disopyramide Review and Disopyramide Label )
- ALPRAZOLAM (View Alprazolam Review and Alprazolam Label )
- ASPIRIN (View Aspirin Review and Aspirin Label )
Cerebral Haemorrhage (7217135-0)
on Jan 06, 2011 Male patient from JAPAN , 85 years of age, was treated with Omepral(View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage. Omepral dosage: N/A.
Patient was taking other medications:
- IRBETAN (View Irbetan Review and Irbetan Label )
- ASPIRIN (View Aspirin Review and Aspirin Label )
- BEZATOL SR (View Bezatol Sr Review and Bezatol Sr Label )
- FRANDOL (View Frandol Review and Frandol Label )
- URIEF (View Urief Review and Urief Label )
Showing 1-25 of 329 Next Page >
Share Your Experience, Discuss with Others|
Side Effects reported to FDA: 329. View All Omepral safety alerts: No Reported deaths: 31 Reported hospitalizations: 121
| ||||||||||||